Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Neuromedin U (NMU) is a neuropeptide isolated from porcine spinal cord in the 1980s, mainly NMU-25 and NMU-8. Its C-terminus has 7 amino acids identical to neuromedin S (NMS), so they bind a common receptor. NMU has two receptors (NMUR1 and NMUR2). NMU and its receptors are widely distributed in the nervous system and many tissues and organs, and have multiple biological functions, including stimulating smooth muscle contraction, regulating food intake and energy balance, affecting gastrointestinal function, reproductive endocrine, sleep and wakefulness.
NMU is widely distributed in the body, and there may be interspecific and developmental differences. In the central nervous system (CNS), the level of NMU in the spinal dorsal horn of the rat is higher than that of the ventral horn. In the brain, NMU immune activity (NMU-LIR) is found in the anterior motor nucleus, reticular nucleus, lateral vestibular nucleus, and trigeminal nucleus. NMU can contract smooth muscle but is species and tissue specific. Pigs' NMU-8 and NMU-25 shrink the uterus of rats, but not the uterine muscles of guinea pigs. NMU concentration-dependently mediates the small intestine contraction of turtles. NMU also mediates canine bladder, stomach, ileum, and colon contractions.
NMU Physiological Functions
NMU is involved in the regulation of food intake and energy balance. ICV injection of NMU in rats can reduce food intake and inhibit food-related behaviors. Intraventricular injection of NMU antiserum can increase food intake in rats, and fasting reduces NMU levels in the ventromedial region of the hypothalamus. The role of NMU in regulating feeding is mainly related to PVN and arcuate nucleus (Arc). Rats were injected with PVN or Arc NMU to immediately reduce food intake. Injecting NMU into the rat ventricle or PVN also increases total exercise activity, body temperature, heat production, and oxygen consumption. NMU injections also increased the body temperature of cattle. The mechanism by which the NMU regulates food intake and energy expenditure remains unclear. It may be related to oxytocin (OT), corticotropin-releasing hormone (CRF), leptin, and α-MSH. Intraventricular injection of CRF in rats inhibited food intake. Inhibition of food intake, oxygen consumption, and increase in body temperature observed after central administration of NMU were absent in CRF knockout mice.
NMU has a certain regulating effect on blood pressure and blood flow. Intravenous injection of NMU in rats can cause rapid and persistent arterial blood pressure rise. NMU increases heart rate, and high concentrations also increase plasma norepinephrine concentrations. These data indicate that NMU can increase sympathetic nerve activity. Intravenous NMU reduced blood flow to the anterior mesenteric artery and portal vein of anesthetized dogs, but had little or no effect on blood flow to the axillary and pancreatic tissues or systemic pulse pressure.
Figure 1. Summary of the multiple functions of NmU in different organs and tissue types. (Martinez, V. G. , et al. 2015)
Impact of NMU on Immunity
In LPS-treated NMU-deficient rats, IL-6 levels were significantly reduced. NMU and NMU-R1 are expressed in wild peritoneal macrophages. LMU treatment causes up-regulation of NMU expression, but down-regulates NMU-R1 expression. NMU-deficient macrophages showed no down-regulation of NMU-R1 expression, and LPS-induced IL-6 production was severely reduced. These results indicate that NMU promotes IL-6 and endotoxin shock in macrophages. Moriyama et al. found that the number of eosinophils in the airways of NMU-deficient mice induced by allergens was reduced. NMU-R1 is highly expressed in eosinophil cell lines. NMU directly induces Ca 2+ mobilization and extracellular/signal-regulated kinase phosphorylation, and also induces cell adhesion to extracellular matrix components (fibronectin and type I collagen) and chemotaxis in vitro. NMU-R1 is also expressed in human peripheral blood eosinophils, and NMU induces cell adhesion in a dose-dependent manner.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.